Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.71 USD | +2.26% | +3.44% | -80.66% |
05-24 | Top Midday Decliners | MT |
05-24 | Genelux Prices $27.5 Million Securities Offering at $4 a Share; Shares Drop | MT |
Sales 2024 * | 5.33K 419K | Sales 2025 * | - | Capitalization | 90.62M 7.12B |
---|---|---|---|---|---|
Net income 2024 * | -27M -2.12B | Net income 2025 * | -35M -2.75B | EV / Sales 2024 * | 17,002 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.83
x | P/E ratio 2025 * |
-2.39
x | Employees | 23 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.44% |
1 day | +2.26% | ||
1 week | +3.44% | ||
1 month | -22.13% | ||
3 months | -62.72% | ||
6 months | -79.67% | ||
Current year | -80.66% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Zindrick
CEO | Chief Executive Officer | 65 | 31/12/09 |
Lourie Zak
DFI | Director of Finance/CFO | 61 | 27/08/23 |
Paul Scigalla
CTO | Chief Tech/Sci/R&D Officer | 79 | 31/08/11 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Tyree
BRD | Director/Board Member | 71 | 01/05/12 |
John Thomas
BRD | Director/Board Member | 66 | 31/08/02 |
John Smither
BRD | Director/Board Member | 71 | 10/09/23 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +3.86% | - |
Date | Price | Change | Volume |
---|---|---|---|
31/05/24 | 2.71 | +2.26% | 249,904 |
30/05/24 | 2.65 | -5.36% | 282,200 |
29/05/24 | 2.8 | +0.36% | 430,847 |
28/05/24 | 2.79 | +6.49% | 894,584 |
Delayed Quote Nasdaq, May 31, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-80.66% | 90.62M | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.61% | 21.96B | |
-8.24% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- GNLX Stock